Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.

Autor: Eton, Omar, Rosenblum, Michael G., Legha, Sewa S., Zhang, Wehei, Jo East, Mary, Bedikian, Agop, Papadopoulos, Nicholas, Buzaid, Antonio, Benjamin, Robert S.
Zdroj: Cancer (0008543X); Jul2002, Vol. 95 Issue 1, p127-134, 8p
Databáze: Complementary Index
Externí odkaz: